CHD Vendee
La Roche-sur-Yon, 85000, France
NCT Number: NCT01881672
Inhalation is a common condition in patients with impaired their awareness requiring protection of the upper airway by endotracheal intubation. This inhalation may lead to chemical pneumonitis and/or bacterial pneumonia. Only the latter requires the administration of antibiotics. Patients developing such a bacterial pneumonia, has a mortality, duration of mechanical ventilation and length of ICU stay increased. However, the proportion of patients with such bacterial pneumonia, bacterial ecology and morbidity that are little known.
The aim of this study is to determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
La Roche-sur-Yon, 85000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
Time frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
Time frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
Time frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
Centre Hospitalier Departemental Vendee
Other
Acronym: SPIRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04675424
ICU Patients, Pathologic Processes
Taoyuan, Taiwan
View Trial DetailsNCT04811638
ICU Acquired Weakness, ICU Patients
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04041817
ICU Patients, Intubation
Clermont-Ferrand, France
View Trial DetailsNCT03977883
ICU Patients, New Onset Atrial Fibrillation
Amiens, France
View Trial Details